157 related articles for article (PubMed ID: 15779380)
1. [Significance of visceral fat syndrome in pathogenesis of impaired glucose tolerance].
Nakamura T
Nihon Rinsho; 2005 Feb; 63 Suppl 2():246-9. PubMed ID: 15779380
[No Abstract] [Full Text] [Related]
2. [Glucose intolerance in visceral fat syndrome].
Matsuzawa Y
Nihon Rinsho; 2002 Jul; 60 Suppl 7():746-51. PubMed ID: 12238130
[No Abstract] [Full Text] [Related]
3. [The cutoff point of visceral fat area as a goal for improving risk factors of arteriosclerosis in patients with glucose intolerance].
Nagano M; Sasaki H; Kumagai S
Nihon Rinsho; 2005 Feb; 63 Suppl 2():417-20. PubMed ID: 15779415
[No Abstract] [Full Text] [Related]
4. [Pathogenesis of insulin resistance in IGT].
Asakawa H; Tokunaga K
Nihon Rinsho; 1997 Nov; 55 Suppl():822-6. PubMed ID: 9434571
[No Abstract] [Full Text] [Related]
5. [Insulin resistance syndrome, visceral fat syndrome].
Nakamura T; Matsuzawa Y
Nihon Rinsho; 1997 Nov; 55 Suppl():792-8. PubMed ID: 9434566
[No Abstract] [Full Text] [Related]
6. [Life style-related disease].
Matsuzawa Y
Nihon Rinsho; 2001 Jan; 59(1):188-94. PubMed ID: 11197854
[TBL] [Abstract][Full Text] [Related]
7. [Diagnostic criteria of insulin resistance and multiple risk factor syndrome].
Hashimoto N; Saito Y
Nihon Rinsho; 2000 Feb; 58(2):405-10. PubMed ID: 10707566
[TBL] [Abstract][Full Text] [Related]
8. Resistin and adiponectin expression in visceral fat of obese rats: effect of weight loss.
Milan G; Granzotto M; Scarda A; Calcagno A; Pagano C; Federspil G; Vettor R
Obes Res; 2002 Nov; 10(11):1095-103. PubMed ID: 12429872
[TBL] [Abstract][Full Text] [Related]
9. Multiple abnormalities in glucose and energy metabolism and coordinated changes in levels of adiponectin, cytokines, and adhesion molecules in subjects with metabolic syndrome.
Salmenniemi U; Ruotsalainen E; Pihlajamäki J; Vauhkonen I; Kainulainen S; Punnonen K; Vanninen E; Laakso M
Circulation; 2004 Dec; 110(25):3842-8. PubMed ID: 15596567
[TBL] [Abstract][Full Text] [Related]
10. [Glucose metabolism in adipose tissue].
Inoue A; Tobe K; Suzuki R; Kadowaki T
Nihon Rinsho; 2002 Oct; 60 Suppl 10():673-80. PubMed ID: 12430302
[No Abstract] [Full Text] [Related]
11. The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk.
Chan JC; Tong PC; Critchley JA
Semin Vasc Med; 2002 Feb; 2(1):45-57. PubMed ID: 16222595
[TBL] [Abstract][Full Text] [Related]
12. Adipotoxicity and the insulin resistance syndrome.
Anderwald C; Roden M
Pediatr Endocrinol Rev; 2004 Mar; 1(3):310-9. PubMed ID: 16437024
[TBL] [Abstract][Full Text] [Related]
13. Impact of visceral adipose tissue on liver metabolism. Part I: heterogeneity of adipose tissue and functional properties of visceral adipose tissue.
Lafontan M; Girard J
Diabetes Metab; 2008 Sep; 34(4 Pt 1):317-27. PubMed ID: 18550411
[TBL] [Abstract][Full Text] [Related]
14. [Visceral fat syndrome].
Tokunaga K; Nakamura T; Kubo M; Matsuzawa Y
Nihon Naika Gakkai Zasshi; 1992 Nov; 81(11):1831-5. PubMed ID: 1479226
[No Abstract] [Full Text] [Related]
15. [Obesity and insulin resistance syndrome].
Tokunaga K; Matsuzawa Y
Nihon Rinsho; 1996 Oct; 54(10):2679-86. PubMed ID: 8914427
[TBL] [Abstract][Full Text] [Related]
16. Adiponectin and metabolic syndrome.
Matsuzawa Y; Funahashi T; Kihara S; Shimomura I
Arterioscler Thromb Vasc Biol; 2004 Jan; 24(1):29-33. PubMed ID: 14551151
[TBL] [Abstract][Full Text] [Related]
17. [Obesity and genesis of glucose intolerance].
Kataoka K; Katsukawa F
Nihon Rinsho; 1998 Jan; 56 Suppl 3():622-8. PubMed ID: 9513488
[No Abstract] [Full Text] [Related]
18. [Application of extended hyperinsulinemic euglycemic clamp in the assessment of insulin sensitivity in obese individuals with glucose intolerance].
Bao YQ; Jia WP; Chen L; Lu JX; Zhu M; Lu W; Xiang KA
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Dec; 28(6):740-4. PubMed ID: 17260458
[TBL] [Abstract][Full Text] [Related]
19. Adipose tissue, insulin resistance and low-grade inflammation: implications for atherogenesis and the cardiovascular harm of estrogen plus progestogen therapy.
Tankó LB; Christiansen C
Climacteric; 2006 Jun; 9(3):169-80. PubMed ID: 16766431
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of disease: adipocytokines and visceral adipose tissue--emerging role in nonalcoholic fatty liver disease.
Schäffler A; Schölmerich J; Büchler C
Nat Clin Pract Gastroenterol Hepatol; 2005 Jun; 2(6):273-80. PubMed ID: 16265231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
